Royalty Pharma plc
RPRX
Rank in Stocks
#861
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Share Price
$62.20
Last synced: 2026-10-21
Market Cap
$27.69B
Change (1 day)
-0.09%
Change (1 year)
68.82%
Country
US
Trade Royalty Pharma plc (RPRX)
Category
Healthcare
Stock price history for Royalty Pharma plc (RPRX)
Highest end of day price: $58.43 on 2026-10-01
Lowest end of day price: $49.50 on 2020-06-01
Lowest end of day price: $49.50 on 2020-06-01
Stock price history of Royalty Pharma plc from 2020 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 27.24% |
| 2025 | 52.96% |
| 2024 | -9.35% |
| 2023 | -31.53% |
| 2022 | 5.51% |
| 2021 | -14.39% |
| 2020 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $46.29 | 37.83% |
SE
|
|
| $171.04 | 23.67% |
FR
|
|
| $116.39 | 58.03% |
US
|
|
| $59.46 | -0.57% |
IT
|
|
| $0.65 | -29.58% |
HK
|
